Protein deep sequencing applied to biobank samples from patients with pancreatic cancer

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 2, 2015, Pages 369-380

  Ansari, Daniel ^a   Andersson, Roland ^a   Bauden, Monika P ^a   Andersson, Bodil ^a   Connolly, Joanne B ^b   Welinder, Charlotte ^c   Sasor, Agata ^a   Marko Varga, György ^c  

^a LUND UNIVERSITY   (Sweden)

^b WATERS CORPORATION   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Early detection; High definition mass spectrometry; Ion mobility; Pancreatic cancer; Serum biomarkers

Indexed keywords

ASTRIN; BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2A; CELL DIVISION PROTEIN KINASE 13; DEATH ASSOCIATED PROTEIN KINASE 1; DST PROTEIN; EXOSC3 PROTEIN; INHBE PROTEIN; KAT2B PROTEIN; KIF20B PROTEIN; PROTEIN; PROTEIN P53; STRUCTURAL MAINTENANCE OF CHROMOSOME PROTEIN 1B; UNCLASSIFIED DRUG; PLASMA PROTEIN; TUMOR MARKER;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HIGH DEFINITION MASS SPECTROMETRY; HUMAN; MALE; MASS SPECTROMETRY; MIDDLE AGED; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; UPREGULATION; BIOLOGY; CASE CONTROL STUDY; COMPARATIVE STUDY; HEALTH CARE FACILITY; METABOLISM; PANCREAS; PANCREAS TUMOR; PROCEDURES; PROGNOSIS; PROTEOMICS;

AGED; BIOLOGICAL SPECIMEN BANKS; BLOOD PROTEINS; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84921020413     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1817-x     Document Type: Article

References (49)

1. Ansari D, Aronsson L, Sasor A, Welinder C, Rezeli M, Marko-Varga G et al (2014) The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science. J Transl Med 12:87. doi:10.1186/1479-5876-12-87
2. Balbas-Martinez C, Sagrera A, Carrillo-de-Santa-Pau E, Earl J, Marquez M, Vazquez M et al (2013) Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet 45:1464–1469. doi:10.1038/ng.2799
3. Bond NJ, Shliaha PV, Lilley KS, Gatto L (2013) Improving qualitative and quantitative performance for MS(E)-based label-free proteomics. J Proteome Res 12:2340–2353. doi:10.1021/pr300776t
4. Bruning A, Matsingou C, Brem GJ, Rahmeh M, Mylonas I (2012) Inhibin beta E is upregulated by drug-induced endoplasmic reticulum stress as a transcriptional target gene of ATF4. Toxicol Appl Pharmacol 264:300–304. doi:10.1016/j.taap.2012.08.011
5. Charrier A, Chen R, Chen L, Kemper S, Hattori T, Takigawa M et al (2014) Connective tissue growth factor (CCN2) and microRNA-21 are components of a positive feedback loop in pancreatic stellate cells (PSC) during chronic pancreatitis and are exported in PSC-derived exosomes. Journal of cell communication and signaling. doi:10.1007/s12079-014-0220-3
6. Chen R, Pan S, Brentnall TA, Aebersold R (2005) Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics 4:523–533. doi:10.1074/mcp.R500004-MCP200
7. Clayton A (2012) Cancer cells use exosomes as tools to manipulate immunity and the microenvironment. Oncoimmunology 1:78–80. doi:10.4161/onci.1.1.17826
8. Dangi-Garimella S, Sahai V, Ebine K, Kumar K, Munshi HG (2013) Three-dimensional collagen I promotes gemcitabine resistance in vitro in pancreatic cancer cells through HMGA2-dependent histone acetyltransferase expression. PLoS ONE 8:e64566. doi:10.1371/journal.pone.0064566
9. Decker GA, Batheja MJ, Collins JM, Silva AC, Mekeel KL, Moss AA et al (2010) Risk factors for pancreatic adenocarcinoma and prospects for screening. Gastroenterol Hepatol (NY) 6:246–254
10. Domon B, Aebersold R (2010) Options and considerations when selecting a quantitative proteomics strategy. Nat Biotechnol 28:710–721. doi:10.1038/nbt.1661
11. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A et al (2013) STRING v9.1: protein–protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41:808–815. doi:10.1093/nar/gks1094
12. Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G et al (2007) Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. Mol Pharmacol 72:152–161. doi:10.1124/mol.106.029025
13. Goonetilleke KS, Siriwardena AK (2007) Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 33:266–270. doi:10.1016/j.ejso.2006.10.004
14. Hanash SM, Pitteri SJ, Faca VM (2008) Mining the plasma proteome for cancer biomarkers. Nature 452:571–579. doi:10.1038/nature06916
15. Harrison B, Kraus M, Burch L, Stevens C, Craig A, Gordon-Weeks P et al (2008) DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing. J Biol Chem 283:9999–10014. doi:10.1074/jbc.M706040200
16. Hashimoto O, Ushiro Y, Sekiyama K, Yamaguchi O, Yoshioka K, Mutoh K et al (2006) Impaired growth of pancreatic exocrine cells in transgenic mice expressing human activin betaE subunit. Biochem Biophys Res Commun 341:416–424. doi:10.1016/j.bbrc.2005.12.205
17. Hsiao YH, Su YA, Tsai HD, Mason JT, Chou MC, Man YG (2010) Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression. Int J Biol Sci 6:428–442
18. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P et al (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801–1806. doi:10.1126/science.1164368
19. Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M et al (2014) Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 289:3869–3875. doi:10.1074/jbc.C113.532267
20. Kim KH, Yoo HY, Joo KM, Jung Y, Jin J, Kim Y et al (2011) Time-course analysis of DNA damage response-related genes after in vitro radiation in H460 and H1229 lung cancer cell lines. Exp Mol Med 43:419–426. doi:10.3858/emm.2011.43.7.046
21. Kim HE, Kim DG, Lee KJ, Son JG, Song MY, Park YM et al (2012) Frequent amplification of CENPF, GMNN and CDK13 genes in hepatocellular carcinomas. PLoS ONE 7:e43223. doi:10.1371/journal.pone.0043223
22. Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R et al (2014) A draft map of the human proteome. Nature 509:575–581. doi:10.1038/nature13302
23. Langley SR, Dwyer J, Drozdov I, Yin X, Mayr M (2013) Proteomics: from single molecules to biological pathways. Cardiovasc Res 97:612–622. doi:10.1093/cvr/cvs346
24. Liggett T, Melnikov A, Yi QL, Replogle C, Brand R, Kaul K et al (2010) Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer 116:1674–1680. doi:10.1002/cncr.24893
25. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD et al (1999) p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19:1202–1209
26. Liu M, Yu H, Huo L, Liu J, Li M, Zhou J (2008) Validating the mitotic kinesin Eg5 as a therapeutic target in pancreatic cancer cells and tumor xenografts using a specific inhibitor. Biochem Pharmacol 76:169–178. doi:10.1016/j.bcp.2008.04.018
27. Mi H, Muruganujan A, Casagrande JT, Thomas PD (2013) Large-scale gene function analysis with the PANTHER classification system. Nat Protoc 8:1551–1566. doi:10.1038/nprot.2013.092
28. Missiaglia E, Blaveri E, Terris B, Wang YH, Costello E, Neoptolemos JP et al (2004) Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 112:100–112. doi:10.1002/ijc.20376
29. Morton JP, Timpson P, Karim SA, Ridgway RA, Athineos D, Doyle B et al (2010) Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 107:246–251. doi:10.1073/pnas.0908428107
30. Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y et al (2013) Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Ann Surg 258:336–346. doi:10.1097/SLA.0b013e3182827a65
31. Polanski M, Anderson NL (2007) A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights 1:1–48
32. Postepska-Igielska A, Krunic D, Schmitt N, Greulich-Bode KM, Boukamp P, Grummt I (2013) The chromatin remodelling complex NoRC safeguards genome stability by heterochromatin formation at telomeres and centromeres. EMBO Rep 14:704–710. doi:10.1038/embor.2013.87
33. Rodriguez-Suarez E, Hughes C, Gethings L, Giles K, Wildgoose J, Stapels M et al (2013) An ion mobility assisted data independent LC-MS strategy for the analysis of complex biological samples. Curr Anal Chem 9:199–211
34. Rosenfeldt MT, O’Prey J, Morton JP, Nixon C, MacKay G, Mrowinska A et al (2013) p53 status determines the role of autophagy in pancreatic tumour development. Nature 504:296–300. doi:10.1038/nature12865
35. Ryan SD, Ferrier A, Kothary R (2012) A novel role for the cytoskeletal linker protein dystonin in the maintenance of microtubule stability and the regulation of ER-Golgi transport. Bioarchitecture 2:2–5
36. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R et al (2008) Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247:456–462. doi:10.1097/SLA.0b013e3181613142
37. Silva JC, Denny R, Dorschel CA, Gorenstein M, Kass IJ, Li GZ et al (2005) Quantitative proteomic analysis by accurate mass retention time pairs. Anal Chem 77:2187–2200. doi:10.1021/ac048455k
38. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ (2006) Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 5:144–156. doi:10.1074/mcp.M500230-MCP200
39. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274. doi:10.1126/science.1133427
40. Suzuki N, Hazama S, Ueno T, Matsui H, Shindo Y, Iida M et al (2014) A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer. J Immunother 37:36–42. doi:10.1097/CJI.0000000000000012
41. Taniuchi K, Nakagawa H, Nakamura T, Eguchi H, Ohigashi H, Ishikawa O et al (2005) Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell. Cancer Res 65:105–112
42. Tessitore A, Gaggiano A, Cicciarelli G, Verzella D, Capece D, Fischietti M et al (2013) Serum biomarkers identification by mass spectrometry in high-mortality tumors. Int J Proteomics 2013:125858. doi:10.1155/2013/125858
43. Thedieck K, Holzwarth B, Prentzell MT, Boehlke C, Klasener K, Ruf S et al (2013) Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells. Cell 154:859–874. doi:10.1016/j.cell.2013.07.031
44. Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ et al (2011) Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 331:593–596. doi:10.1126/science.1200801
45. Tingstedt B, Johansson P, Andersson B, Andersson R (2007) Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. Scand J Gastroenterol 42:754–759. doi:10.1080/00365520601058452
46. Verdone L, Caserta M, Di Mauro E (2005) Role of histone acetylation in the control of gene expression. Biochem Cell Biol 83:344–353. doi:10.1139/o05-041
47. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378:607–620. doi:10.1016/S0140-6736(10)62307-0
48. Wilhelm M, Schlegl J, Hahne H, Gholami AM, Lieberenz M, Savitski MM et al (2014) Mass-spectrometry-based draft of the human proteome. Nature 509:582–587. doi:10.1038/nature13319
49. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B et al (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114–1117. doi:10.1038/nature09515